Trials / Conditions / Stage IIIC Esophageal Adenocarcinoma

Stage IIIC Esophageal Adenocarcinoma

4 registered clinical trials studyying Stage IIIC Esophageal Adenocarcinoma.

Status	Trial	Sponsor	Phase
Terminated	Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combina NCT02392377	Case Comprehensive Cancer Center	Phase 2
Suspended	Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advan NCT02366819	University of Chicago	Phase 4
Terminated	Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Wh NCT02234180	Academic and Community Cancer Research United	Phase 2
Completed	Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gast NCT01178944	Roswell Park Cancer Institute	Phase 2